MORAVCOVA, Katarina, Marketa SOVOVA, Jaromir OZANA, Martina KARBANOVÁ, Jan KLASEK, Agnieszka Barbara KOLASINSKA a Eliska SOVOVA. Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial. Nutrients. Basel: MDPI, 2024, roč. 16, č. 10, s. 1-13. ISSN 2072-6643. Dostupné z: https://dx.doi.org/10.3390/nu16101510.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
Autoři MORAVCOVA, Katarina (203 Česká republika), Marketa SOVOVA (203 Česká republika), Jaromir OZANA (203 Česká republika), Martina KARBANOVÁ (203 Česká republika, domácí), Jan KLASEK (203 Česká republika), Agnieszka Barbara KOLASINSKA (203 Česká republika) a Eliska SOVOVA (203 Česká republika).
Vydání Nutrients, Basel, MDPI, 2024, 2072-6643.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.900 v roce 2022
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/nu16101510
UT WoS 001231311000001
Klíčová slova anglicky obesity; digital therapeutics; lifestyle intervention; diabetes mellitus type 2; insulin resistance
Štítky 14110525
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 10. 6. 2024 08:33.
Anotace
Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.
VytisknoutZobrazeno: 22. 7. 2024 22:25